| Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer S Djalalov, J Beca, JS Hoch, M Krahn, MS Tsao, JC Cutz, NB Leighl J Clin Oncol 32 (10), 1012-1019, 2014 | 104 | 2014 |
| A review and meta-analysis of colorectal cancer utilities S Djalalov, L Rabeneck, G Tomlinson, KE Bremner, R Hilsden, JS Hoch Medical Decision Making 34 (6), 809-818, 2014 | 52 | 2014 |
| A review of economic evaluations of genetic testing services and interventions (2004–2009) S Djalalov, Z Musa, M Mendelson, K Siminovitch, J Hoch Genetics in Medicine 13 (2), 89-94, 2011 | 40 | 2011 |
| Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine S Djalalov, J Yong, J Beca, S Black, G Saposnik, Z Musa, K Siminovitch, ... Molecular diagnosis & therapy 16, 389-399, 2012 | 28 | 2012 |
| Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor–positive early breast cancer in Canada S Djalalov, J Beca, E Amir, M Krahn, ME Trudeau, JS Hoch Current Oncology 22 (2), 84-96, 2015 | 20 | 2015 |
| Pilot of three objective markers of physical health and chemotherapy toxicity in older adults T Hsu, R Chen, SCX Lin, S Djalalov, A Horgan, LW Le, N Leighl Current oncology 22 (6), 385-391, 2015 | 14 | 2015 |
| Policy reforms and agriculture development in Central Asia S Djalalov, SC Babu Springer Science & Business Media, 2006 | 14 | 2006 |
| A comparison of different analysis methods for reconstructed survival data to inform cost‑effectiveness analysis S Djalalov, J Beca, EM Ewara, JS Hoch Pharmacoeconomics 37, 1525-1536, 2019 | 11 | 2019 |
| Роль систематического обзора и метаанализа при оценке технологий в здравоохранении СЧ Джалалов, ДХ Джалалова, ХД Стюарт Медицинские технологии. Оценка и выбор, 10-16, 2012 | 11 | 2012 |
| Economic evaluation of smoking cessation in Ontario's regional cancer programs S Djalalov, L Masucci, W Isaranuwatchai, W Evans, A Peter, R Truscott, ... Cancer medicine 7 (9), 4765-4772, 2018 | 9 | 2018 |
| Implicit taxation of Uzbekistan’s cotton sector: Estimation and policy consequences’ S Djalalov Paper presented ate the SOAS Conference ‘Cotton in Central Asia, 3-4, 2005 | 9 | 2005 |
| Обзор руководств по оценке технологий в здравоохранении: основные условия построения экономических моделей СЧ Джалалов, ДХ Джалалова, ХД Стюарт Медицинские технологии. Оценка и выбор, 35-41, 2012 | 8 | 2012 |
| Tendencies in Uzbekistan Farm Production S Djalalov, CM Gemma Review (Tashkent: Centre for Effective Economical Policy), 2001 | 8 | 2001 |
| The Sustainable Development of Water User’s Associations in Uzbekistan S Djalalov Policy Reforms and Agriculture Development in Central Asia, 371-393, 2006 | 6 | 2006 |
| Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View S Djalalov, D Djalalova, M Krahn, N Matveev, JS Hoch Value in health regional issues 19, 138-144, 2019 | 5 | 2019 |
| Интерпретация результатов оценки медицинских технологий СЧ Джалалов, ДХ Джалалова, ХД Стюарт Медицинские технологии. Оценка и выбор, 19-28, 2014 | 5 | 2014 |
| Impact of policy reforms on farm production in Uzbekistan S Djalalov, M Gemma Policy Reforms and Agriculture Development in Central Asia, 239-255, 2006 | 5 | 2006 |
| Economic evaluation of compression stockings for the prevention of venous leg ulcer recurrence in Ontario S Djalalov, S Sehatzadeh, DH Keast, WWL Wong Journal of wound care 29 (3), 141-151, 2020 | 4 | 2020 |
| Анализ решений в медицине: принципы построения древа решений СЧ Джалалов, ДХ Джалалова, ХД Стюарт Медицинские технологии. Оценка и выбор, 29-36, 2014 | 4 | 2014 |
| Разделение рисков в онкологии СЧ Джалалов, ДХ Джалалова, ХД Стюарт Медицинские технологии. Оценка и выбор, 63-69, 2013 | 4 | 2013 |
